NEW YORK--(BUSINESS WIRE)--Synchron, the brain-computer interface (BCI) company developing endovascular technology to restore functionality in individuals with motor impairment, today announced the ...

A new protocol will allow users implanted with Synchron’s brain-computer interface (BCI) device to control iPhone, iPad and Apple Vision Pro directly with their thoughts without the need for physical ...

A new brain implant now lets people control Apple devices, such as iPads, iPhones and the Vision Pro, using only their thoughts. Synchron, an endovascular brain-computer interface (BCI) company based ...

Synchron, a New York, NY-based manufacturer of non-surgical brain-computer interface technology, said it has raised a $200 million series D round. The funds are expected to accelerate ...

New York-based Synchron, a brain-computer interface (BCI) company, announced it will be the first BCI company to reach native integration with Apple's new BCI Human Interface Device (BCI HID) profile ...

Apple has worked on a new standard with Synchron on a brain-computer interface that, among other things, aids folks with disabilities, according to the Wall Street Journal. Synchron has made a ...

Neurotech company Synchron has been making massive strides over the past couple of years. It's just announced that a trial participant has used its brain-computer interface (BCI) to turn on the lights ...

The round was led by Double Point Ventures, alongside existing investors ARCH Ventures, Khosla Ventures, Bezos Expeditions, NTI and METIS. New investors include the Australian National Reconstruction ...

Synchron has raised $200 million to support commercialization of its brain computer interface platform, the company said Thursday. The Series D round will fund preparations to launch Synchron's ...